Evidence map›Paper›PMID 42182124›Full record

ArticlebioRxiv : the preprint server for biology2026

Adaptation of α-synuclein fibrils following multiple system atrophy transmission to mice.

Mylan Mayer, Chase R Khedmatgozar, Gianna Zinnen, Matthew P Frost, Patricia M Reis, Sara A M Holec, Melissa Dexter, Arthur A Melo, Eric Tse, Gregory E Merz and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mylan MayerInstitute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-0322-5689
Chase R KhedmatgozarDepartment of Microbiology, Immunology, & Pathology and Prion Research Center, Colorado State University, Fort Collins, CO, USA.ORCID 0000-0002-2639-1578
Gianna ZinnenDepartment of Microbiology, Immunology, & Pathology and Prion Research Center, Colorado State University, Fort Collins, CO, USA.
Matthew P FrostDepartment of Biology, University of Massachusetts Amherst, Amherst, MA, USA.ORCID 0000-0002-9973-2572
Patricia M ReisDepartment of Biology, University of Massachusetts Amherst, Amherst, MA, USA.ORCID 0000-0002-4211-2567
Sara A M HolecDepartment of Microbiology, Immunology, & Pathology and Prion Research Center, Colorado State University, Fort Collins, CO, USA.ORCID 0000-0003-0800-1115
Melissa DexterDepartment of Microbiology, Immunology, & Pathology and Prion Research Center, Colorado State University, Fort Collins, CO, USA.
Arthur A MeloInstitute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-9345-1462
Eric TseInstitute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Gregory E MerzInstitute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-0842-4935
Amanda L WoermanDepartment of Microbiology, Immunology, & Pathology and Prion Research Center, Colorado State University, Fort Collins, CO, USA.ORCID 0000-0003-4029-1968

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Sudeshna Das · 2019 to 2026
$36.5M
Effect of Agent and Host Factors on Alpha-Synuclein Strain PathogenesisR01NS121294 · NINDS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI Amanda L. Woerman · 2022 to 2026
$2.9M
Predoctoral Training in Quantitative Cell & Molecular BiologyT32GM132057 · NIGMS · COLORADO STATE UNIVERSITY · PI Karen Marie Dobos, Brian Munsky · 2019 to 2026
$2.9M
Structure-function relationships in alpha-synuclein strain biologyRF1NS143175 · NINDS · COLORADO STATE UNIVERSITY · PI WOERMAN, AMANDA L. · 2025 to 2025
$2.7M
Untangling the bidirectional relationship between the spread of pathological protein aggregates, sleep, and circadian clock disruption in neurodegenerative diseaseR01AG082349 · NIA · COLORADO STATE UNIVERSITY · PI Ilia Nicholas Karatsoreos, Amanda L. Woerman · 2024 to 2026
$2.2M
A Novel Gene Therapy Approach to Prevent Alpha-synuclein Misfolding in Multiple System AtrophyR21NS127002 · NINDS · COLORADO STATE UNIVERSITY · PI WOERMAN, AMANDA L. · 2023 to 2024
$422k
A transcriptomics-based approach to identify quantitative biomarkers for multiple system atrophyF31NS139652 · NINDS · COLORADO STATE UNIVERSITY · PI Chase Reza Khedmatgozar · 2024 to 2026
$86k
NIA NIH HHS P30 AG062421NIA NIH HHS R01 AG082349NIGMS NIH HHS T32 GM132057NINDS NIH HHS F31 NS139652NINDS NIH HHS R01 NS121294NINDS NIH HHS R21 NS127002NINDS NIH HHS RF1 NS143175
6 · The paper itself

Abstract

Synucleinopathies are a group of neurodegenerative diseases characterized by the presence of misfolded α-synuclein inclusions which cause progressive disease by spreading throughout the brain in a prion-like manner. Throughout the neurodegenerative disease field, the ability of a single protein to give rise to multiple distinct clinical disorders is explained by the strain hypothesis, or the idea that the misfolded protein conformation determines the resulting disease. This was initially shown using transmission studies in cell lines and mouse models; more recently cryoelectron microscopy (cryo-EM) validated this idea by identifying distinct α-synuclein filament folds in brain tissues from patients with Parkinson's disease, multiple system atrophy (MSA), and juvenile-onset synucleinopathy. However, very little is known about the α-synuclein filament structures that form in animal models of these disorders, and thus their relevance to human disease and suitability as models for therapeutic development remains a question. Here we report the first atomic resolution cryo-EM structures of α-synuclein fibrils from an MSA patient sample before and after transmission to a transgenic mouse model of disease. Our findings indicate that while distinct adaptations occur during fibril replication in the mouse host, key structural facets are maintained, validating the merits of this transmission model for supporting preclinical research on MSA.

Identifiers

PMID42182124
PMCPMC13192624

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.